Skip to main content
Edmond Fitzgibbon, MD, Ophthalmology, Bethesda, MD

Edmond Joseph Fitzgibbon MD

Ophthalmology•Bethesda, MD

Neuro-Ophthalmology

Neuro-ophthalmology National Eye Institute, NIH Bethesda MD

Join to View Full Profile

  • Rockville PikeRm 2A50Bethesda, MD 20892

  • Phone+1 301-496-7144

  • Fax+1 301-402-0511

Dr. Fitzgibbon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Fitzgibbon's Full ProfileAlready have an account?

Summary

  • Dr. Edmond Fitzgibbon is an ophthalmologist based in Bethesda, MD, specializing in neuro-ophthalmology. He completed an internship in internal medicine and residency in ophthalmology, with experience in general/comprehensive ophthalmology and neuro-ophthalmology. Dr. Fitzgibbon has contributed to research, having published several articles in noteworthy journals such as the Journal of Vision, NEJM, and JAMA. He has been involved in clinical trials focusing on neuro-degenerative diseases. Dr. Fitzgibbon served on the board of the North American Neuro-Ophthalmology Society and was President from 2016 to 2018. He is a Fellow of the American Academy of Ophthalmology.

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Ophthalmology, 1979 - 1984
  • Albany Medical Center
    Albany Medical CenterInternship, Internal Medicine, 1978 - 1979
  • Albany Medical College
    Albany Medical CollegeClass of 1978

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1990 - 2026
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • President North American Neuro-Ophthalmology Society, 2016-2018
  • Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Ocular Adverse Effects of Infigratinib, a New FGFR Tyrosine Kinase Inhibitor
    Ocular Adverse Effects of Infigratinib, a New FGFR Tyrosine Kinase InhibitorSeptember 1st, 2020

Grant Support

  • Neuro-Ophthalmic Mechanisms Of DiseaseNational Eye Institute2002–2008
  • Neuro-ophthalmic Mechanisms Of DiseaseNATIONAL EYE INSTITUTEPresent

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Edmond Fitzgibbon, Dr. Edmond Fitzgibbon, MD, Dr. E Fitzgibbon, Dr. Edmond Joseph Fitzgibbon